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Abstract
Introduction. Breast cancer is the most common cancer in Indonesia with incidence rate 40.3 per 100.000 women and mortality rate 16.6 per
100.000 women. On early stage, the decision for operative procedure (i.e. mastectomy) requires intraoperative frozen section to assess malignancy;
which is mostly unavailable in secondary hospitals. The triple diagnostic (TD) test consists of physical examination, breast ultrasonography and
fine needle aspiration biopsy is an accurate and simple preoperative diagnostic method that may solve the problem. The study aimed to find out
conformance of the triple diagnostic to histopathology findings in those with breast lump where the malignancy was suspected.
Method. A study of diagnostic accuracy conducted enrolling subjects with suspected malignant breast lump managed in dr Cipto Mangunkusumo
General Hospital (RSCM) and Persahabatan Hospital (RSP) in period of February 2016 to August 2017 who met the criteria: those underwent
preoperative triple diagnostic, intraoperative frozen section and histopathology examination. The conformance of TD and frozen section were
compared to histopathology findings. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy were
the focuses of the study.
Results. There were 33 subjects enrolled (prevalence of 4.3%), mean age of 49.6 years ± 10.9, were above 40 years (78.8%). Tumor size of 2–5
cm found in 63.6% subjects, and the most histopathology finding was invasive carcinoma (84.8%). Frozen section showed sensitivity of 96.8%,
specificity of 100%, PPV of 100%, NPV of 66.7% and accuracy of 97.0%. TD showed sensitivity of 77.4%, specificity of 100%, PPV of 100%),
NPV of 22.2% and accuracy of 78.8% (p = 0.016).
Conclusion. Triple diagnostic reaches up to 78% accuracy on early stage breast cancer may be used secondary hospital in Indonesia whenever
frozen section is unavailable.
Keywords: early stage breast cancer, triple diagnostic, frozen section, histopathology

Introduction
Breast cancer is the most common cancer with incidence rate 40.3
per 100,000 women or 48,998 new cases per year (meanings that
there are six new cases of breast cancer each hour) and a mortality
rate as high as 16.6 per 100,000 women or as many as 19,750 women
per year.1 According to Indonesian national health insurance (BPJS),
in 2015 total expenses for cancer was 1.318 trillion rupiah with a total
of 724,636 cases in Indonesia.2 In 2014–2016, there were 335 new
breast cancer cases in dr. Cipto Mangunkusumo General Hospital
(RSCM),3 and Rachmawati reported (2012) out of 126 there were
112 of cases (88.88%) admitted as advanced stage at RSCM.4
The final diagnosis of breast cancer is established with histopathology
findings which is set as the gold standard.5 Nowadays, the method of
diagnostic in RSCM was in accordance with the guideline provide by
Association of Indonesian Oncology Surgeons (PERABOI), namely
history taking, physical examination, tissue biopsy, ultrasonography
or mammography, surgical excision with frozen section that may
leading to decide the resection of choice (for instance, mastectomy).6
Unfortunately the facility to provide histopathology and frozen
section examination is not available in all hospital due to the
distribution of pathologist as well as the facilities; thereby influencing

the prognosis.7,8 In this unavailability, other diagnostic method is
needed. An alternative is a simple triple diagnostic test.8
Triple diagnostic test introduced in 1970 as a diagnostic method in
evaluation of breast lumps. This test consists of three components
namely physical examination, ultrasound and/or mammography, and
fine needle aspiration biopsy (FNAB).8 The combination of the three
components is essential: 1) Clinical examination independently
showed the specificity, sensitivity, and accuracy >80%; however it is
not a stand–alone method as the basis for definitive treatment, 2)
Ultrasound and/or mammography may detect a clinically unpalpable
small tumor showed the specificity, sensitivity, and accuracy >70%.
However, the limitation of a method is not recommended for women
<35 years due to high breast density and the facility is not available in
all hospital, 3) Cytology examination of specimen taken by fine
needle aspiration is an early detection tools with the specificity,
sensitivity, and accuracy >87%.8 Triple diagnostic has been shown to
be useful as an accurate diagnostic tool, technically simple, and
proven to reduce the total medical expenses as well as morbidity.9
Should the diagnosis established preoperatively, then the benefits are:
1) Patients and their family may be given a detailed operative
measures that will be carried out which is mutilating in nature, so the
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patient is well prepared psychologically; 2) Patients with benign
abnormalities do not need to undergo further excessive diagnostic test
for staging purpose; and 3) Intra–operative frozen section will be
unnecessary and therefore may reduce surgical duration and
operational expenses, as well as anesthesia.8
Currently, triple diagnostic has not been used as a diagnostic guide in
patients with breast lumps at RSCM and Persahabatan Hospital
(RSP). Thus, the accuracy of its predictive value is unknown.
Method
A diagnostic study proceeded on early stage breast cancers managed
at RSCM and RSP in period of February 2016 – August 2017 to find
out the sensitivity, specificity, positive predictive value, negative
predictive value, and accuracy of triple diagnostic and frozen section
compared to the gold standard (histopathology). Triple test score
found from triple diagnostic method were classified to concordant
malignant (TTS = 9), suspicion malignant (TTS 4–8) and concordant
benign (TTS = 3). In this study, only subjects with TTS 4–8 were
enrolled and were subjected to further classified into low margin
(TTS 4–6) and high margin (TTS 7–8). Patients who came for the
first time or who came to control at surgical oncology clinic in both
hospitals within the period was enrolled. A consecutive sampling was
used, and data were collected from medical report in both hospitals.
Subjects were informed who agreed to participate and signed the
consent. Males, those whose loss to follow up, and those with
incomplete data were excluded.
Descriptive analysis addressed for demographic, clinical, and
laboratory characteristics were expressed in percentage. Data were
subjected to analysis using SPSS ver. 20.0 for Macintosh. Normality
test carried out on numerical, and means were used in normal
distribution. Analysis carried out using McNemar test for triple
diagnostic variables. The sensitivity, specificity, positive predictive
value (PPV), negative predictive value (NPV), and accuracy of triple
diagnostic was determined using the standard formula: sensitivity =
TP/(TP + FN); specificity = TN/(TN + FP); positive predictive value
= TP/(TP + FP); negative predictive value = TN/(TN + FN); and
accuracy = (TP + TN)/(TP + TN + FP + FN), with TP is true positive;
TN, true negative; FP, false positive; and FN, false negative.
Results
There were 1,095 cases of breast cancer managed in such a period.
However, only 41 subjects referred to the early stage (stage 1–2)
breast cancer. Eight out of 41 subjects were excluded as the data
incomplete. Out of a total subject enrolled, 33 subjects were analyzed,
whereas 26 subjects managed at RSCM and 7 subjects at RSP.
The subjects were classified based on the staging and TNM system.
Sixteen out of thirty–three subjects were of stage IIB (48.6%) as seen
in Table 1.
Table 1. Distribution of subjects based on TNM staging
Stage
TNM
Total
(%)
IA
T1N0M0
3
9
IB
T2N0M0
14
42.4
IIA
T1N1M0
0
0
IIB
T2N1M0
7
21.3
T3N0M0
9
27.3

malignancy had tumor size measuring 2 to 5 cm (63.6%) and of the
most histopathology finding was invasive carcinoma (84.8%) (Table
2).
Table 2. Subject characteristics based on age, tumor size, and histopathology
Variables
Total
Mean ± SD Age (years)
49.6 ± 10.9
Age
<40 years
7
>40 years
26
Tumor Size
<2cm
3
2–5cm
21
>5cm
9
Histopathology
Non–invasive carcinoma
2
Invasive carcinoma
28
Other subtypes
3

(%)
NA
21.2
78.8
9.1
63.6
27.3
6.1
84.8
9.1

In the study on physical examination, all subjects were categorized as
suspicion malignant (100%). While as study on ultrasound
examination, three subjects (9.1%) were benign, fourteen subjects
(42.4%) were suspicion malignant, and 16 subjects (48.5%) were
malignant. On FNAB study, two subjects (6.1%) were benign,
fourteen subjects (42.4%) were suspicion malignant and 17 subjects
(51.5%) were malignant. On histopathology study, thirty–one
subjects (93.9%) were malignant and 2 subjects (6.1%) were benign.
On the study, all subjects were of suspicion malignant category (TTS
4–8), nine subjects (27.3%) were suspicion malignant of low margin
(TTS 4–6) and 24 subjects (72.7%) were suspicion malignant of high
margin (TTS 7–8). The frozen section showed three subjects (9.1%)
were of benign category, two subjects (6.1%) were of suspicion
malignant and 28 subjects (84.8%) were of malignant category
(Table 3). In this study, all subjects who were categorized as suspicion
malignant in each component of triple diagnostic as well as frozen
section were categorized as malignant, therefore two categories
namely benign and malignant were created. Hereafter, those data
were compared with the histopathology as the gold standard.
Table 3. Triple diagnostic components and frozen section
Component of investigation
Total
Physical examination
Benign
0
Suspicion malignant
33
Malignant
0
Ultrasound
Benign
3
Suspicion malignant
14
Malignant
16
FNAB
Benign
2
Suspicion malignant
14
Malignant
17
Triple diagnostic
Suspicion malignant low margin
9
(TTS 4–6)
Suspicion malignant high margin
24
(TTS 7–8)
Frozen section
Benign
3
Suspicion malignant
2
Malignant
28
Histopathology
Benign
Malignant

2
31

%
0
100
0
9.1
42.4
48.5
6.1
42.4
51.5
27.3
72.7

9.1
6.1
84.8
6.1
93.9

Age distribution of these subjects of the early stage (stage I–II) was
49.6 years ± 10.9, mostly (78.8%) of >40 years. Subjects with
21

Comparison of frozen section with histopathology finding
Comparison of frozen section with histopathology finding showed
that out of all subjects categorized as malignant, thirty subjects
(90.9%) were histopathologically confirmed malignant. Out of 3
subjects categorized as benign, two subjects (6.1%) were
histopathologically confirmed benign and 1 subject (3.0%) were
histopathologically malignant (Table 4). In this study, McNemar test
for conformance of the three triple diagnostic components to frozen
section and histopathology showed a p value of 1.000.
Comparison of triple diagnostic with histopathology finding
Comparison of triple diagnostic with histopathology finding showed
all 24 subjects categorized as suspicion malignant of high margin
(TTS 7–8) were confirmed on histopathologically malignant. Out of
nine subjects categorized as suspicion malignant of low margin (TTS
4–6), seven subjects were confirmed histopathologically malignant
and only 2 subjects were histopathologically benign (Table 5).
McNemar test carried out for conformance showed p value of 0.016.
Table 4. Distribution based on frozen section and histopathology results
Histopathology
Results
Malignant
%
Benign
%
Total
Malignant
30
90.9
0
0
30
Frozen
Benign
1
3.0
2
6.1
3
Section
Total
31
93.9
2
6.1
33
Table 5. Distribution based on triple examination and histopathology results
Histopathology
Results
Malignant
%
Benign % Total
Suspicion
malignant high
24
72.7
0
0
24
margin (TTS
Triple 7–8)
Test
Suspicion
Score malignant low
7
21.2
2
6.1
9
(TTS) margin (TTS
4–6)
Total
31
93.9
2
6.1
33
*McNemar Test: p = 0.016

%
90.9
9.1
100

%
72.7

27.3
100

Comparison of sensitivity, specificity, positive predictive value,
negative predictive value, and accuracy based on each examination
component.
The sensitivity of physical examination alone to histopathology
finding was 100%, with specificity 0%. Positive predictive value was
93.9% and negative predictive value was unable to measured. The
accuracy of physical examination alone was 93.9%. The sensitivity
of ultrasound examination to histopathology finding was 93.5%, with
lower specificity (50%). Positive predictive value was 96.7%, was
found much higher than the negative predictive value (33.3%). The
accuracy of ultrasound with histopathology finding was 90.9%. The
sensitivity of FNAB examination alone to histopathology finding
was 96.8%, much higher than its specificity (50%). The positive
predictive value (96.8%) was also found higher than the negative
predictive value (50%). The accuracy of FNAB examination alone,
as a single component to histopathology finding was 93.9%. The
sensitivity and specificity of frozen section to histopathology was
found similar, which was 96.8% and 100%. The positive predictive
value (100%) was higher than the negative predictive value (66.7%).
The accuracy of frozen section to histopathology was 97.0% (Table
6).
The sensitivity of triple diagnostic to histopathology finding showed
a lower value compared to its specificity, which was 77.4%
compared to 100%. Meanwhile, its positive predictive value was

higher than the negative predictive value, which was 100% compared
to 22.2%. The accuracy of triple diagnostic examination to
histopathology was 78.8% (Table 6).
Table 6. Sensitivity, specificity, positive predictive value, negative predictive value, and
accuracy based on examination methods
Component of investigation
Physic
al

FNA
B

95% CI

TD

95% CI

96. (83.8,99.
100
96.8
8
4)
10
(34.2,10
0
50
50
0
0)
96.
10
(88.7,10
PPV (%)
93.9
96.8
7
0
0)
33.
66. (20.8,93.
NPV (%)
NA
50
3
7
9)
Accuracy
90.
97. (84.7,99.
93.9
93.9
(%)
9
0
5)
US: ultrasound, FS: frozen section, TD: triple diagnostic

77.
4
10
0
10
0
22.
2
78.
8

(60.2,88.
6)
(34.2,10
0)
(86.2,10
0)
(6.3,54.7
)
(62.3,89.
3)

Sensitivity
(%)
Specificity
(%)

US
93.
5

FS

Discussion
This is the first study to investigate the triple diagnostic test
conformance to histopathology finding enrolling subjects managed at
RSCM and RSP. Even though a total of 1,095 breast cancer cases
were managed within period of April 2016 to August 2017, the study
only focused on early stage breast cancer with the prevalence of
4.3%. Thus, only 41 subjects were enrolled throughout 16 months of
data collection, and out of these only 33 subjects were analyzed. The
number of subjects enrolled was found lesser than minimal number
of samples required for a diagnostic study as eight subjects did not
complete the triple diagnostic test or frozen section examination
before histopathological investigation. This is found to be reasonable
as both hospital of RSCM and RSP are the top referrals characterized
with those in advanced stages.
Out of 33 subjects analyzed, mostly were of 49.6 years and 78.8%
were more than 40 years. This finding was in line with study of
Kharkwal et al in Asian population who found population of 35–70
years. He found that 60% of breast cancer were diagnosed at the age
of 41 to 60 years with average of 50 years. Study of Mu et al on 20–
80 years population with early stage cancer showed the average age
of 45 years.10 In the United States, breast cancer were mostly found
in average of 40–70 years, with tumor size of 2 to 4.9 cm at the first
diagnosis.11 While as in United Kingdom, the first diagnosed is at 60–
70 years, with tumor size of 2 to 5 cm. The contributing factors to age
different of Asian, American and England have not been established.
However, it is considered that BRCA1 and 2 gene variations in
different population were responsible.12
In the study, 63.6% subjects categorized as suspected malignant
measuring 2 to 5 cm tumor size, and 84.8% were invasive carcinoma
on histopathological findings. Subject characteristics was in line with
previous studies found the first diagnosis is in average of 40–50 years,
and more aggressive tumors as invasive ductal carcinoma and
invasive lobular carcinoma.13,14
The physical examination showed sensitivity of 100% and specificity
of 0% was found conformance to histopathological investigation.
Positive predictive value was 93.9% and none negative predictive
value found because unable to be calculated. The accuracy of
physical examination to histopathological investigation was 93.9%.
Studies showed that physical examination is subjective but also
objective and referred to investigator dependent. Thus, should never
be used independently in the establishment of the malignancy of
22

breast lesion. However, it’s an essential supporting component of
triple diagnostic test should be carried out first.15
Sensitivity of ultrasound to histopathological finding was 93.5%, and
less specificity of 50%. Positive predictive value was found higher
(96.7%) than negative predictive value (33%). The accuracy of
ultrasound to histopathological finding was 90.9%. Paramita et al
found the accuracy in their study was 70.96% with false positive
value of 45.45% and false negative value of 20%.16 Since ultrasound
is operator dependent, the higher accuracy of ultrasound in the study
may correlate to the fact that 78.8% of subjects were carried out by
experienced radiologist in breast–division (RSCM) and 31.2% were
carried out by experienced radiologist in thoracic subdivision (RSP).
Nevertheless, study by Kim et al in Korea found the sensitivity of
ultrasound for breast cancer detection compared to histopathological
examination was 98.4%.17 Hasni et al., found that ultrasound for
breast cancer detection has sensitivity of 100%, specificity of 85.7%
and accuracy of 87.5%; all procedures were carried out by the same
person, i.e. the resident of radiology training of the third years.18
The sensitivity of FNAB to histopathological examination was found
higher than its specificity (96.8% compare to 50%). Positive
predictive value was found higher (96.8%) than negative predictive
value (50%). The accuracy of FNAB to histopathological
investigation was 93.9%. In the study, the procedure of FNAB is not
guided by ultrasound, let a lower specificity value found. Study
showed that ultrasound–guided FNAB is the most dependable
element of TTS with sensitivity of 80–91%, specificity of 79–100%,
and accuracy of 87%.19 This study finding was in line with Kaufman
et al who found the sensitivity, accuracy, positive predictive value,
and negative predictive value of FNAB in breast cancer detection was
93%, 95%, 96%, and 94% respectively.20 Katti et al also found high
sensitivity of 97.56%, with accuracy of 98.94%, positive predictive
value of 97.56%, negative predictive value of 98.18%, and specificity
of 100%.21 FNAB is influenced by many factors i.e. site of the lump
(either superficial or deep), technique in taking the specimen, staining
method, and even the pathologist experience interpretation.22
Analysis of sensitivity and specificity of frozen section to
histopathological examination is 96.8% and 100% respectively. The
positive predictive value of frozen section was higher than its
negative predictive value; i.e. 100% compared to 66.7%. While as the
accuracy of frozen section compared to histopathological
examination was 97.0%. Boughey et al found the sensitivity was
94.7%, with specificity of 100%, positive predictive value of 100%,
negative predictive value of 92.8%, thereby may reduce
reoperation.23 Accuracy of frozen section is influenced by various
factors i.e. slicing technique and technique of specimen collection
technique, and interpreter.24 In the study, a high accuracy reflecting
appropriate specimen collection, technique and interpretation by
experienced pathologist. However, frozen section has limitations, i.e.
high cost and need a longer surgical duration, and available
pathologist in operating theater. Those components are often not
available in Indonesia. According to Indonesian Ministry of Health,
a total 610 pathologists were not distributed well in Indonesia.
The samples of this study were categorized in two groups for data
analysis i.e. suspected malignant low margin (TTS 4–6, 27.3%) and
high margin (TTS 7–8, 72.7%). Study of Mokri et al showed that
TTS 4–5 shows the tendency to be benign and TTS>6 were
frequently malignant, thereby should be treated as malignant lesions
with 100% sensitivity.25 Conformance analysis of triple diagnostic
test to histopathological examination showed lower sensitivity
(77.4%) compared to specificity (100%). While the positive
predictive value is much higher than negative predictive value (100%

compared to 22%). The accuracy of triple diagnostic test to
histopathological examination was 78.8%. High positive predictive
value (100%) and satisfactory accuracy value (78.8%) is very
important to clinicians for establishing the diagnosis of breast cancer
using merely triple diagnostic method.
This study findings are slightly different to study of Novianto et al
who found sensitivity of 94%, specificity of 95%, positive predictive
value of 96%, negative predictive value of 93%, and accuracy of 94%
with the combination of clinical examination, breast ultrasound and
cytologic investigation taken by aspiration biopsy on early stage
breast cancer.15 The difference is those carried out by Novianto et al
were operator dependent physical examination. In RSCM, all the
ultrasound and FNAB performed and verified by both radiologists
and pathologists, let minimize examination biases. However,
physical examinations were carried out by surgical residents or
trainees.
Accuracy of triple diagnostic test in this study is lower than frozen
section (78.8% compared to 97.0%). However, triple diagnostic test
is quite accurate and simple which is useful should frozen–section is
not available. This finding is like the study of Kauffman et al
indicating the triple diagnostic test is non–concordant; should it
concordant then accuracy may up to 77–99%.20 In addition, frozen
section requires intra–operative pathologists who are frequently
unavailable in all Indonesian hospital due the distribution. In such a
case, triple diagnostic test is the best option to establish the diagnosis,
decision making, reduces reoperation, and reduces duration of
surgery. Kharkwal et al in India showed this triple diagnostic is an
accurate non–invasive diagnostic method should be considered for
diagnosis and treatment.22
Conclusion
The study found prevalence of early stage breast cancer in RSCM
and RSP is 4.3%. The conformance of triple diagnostic test showed
sensitivity of 77.44%, specificity of 100%, positive predictive value
of 100%, negative predictive value of 22.2%, and accuracy of 78.8%.
Frozen section showed sensitivity of 96.8%, specificity of 100%,
positive predictive value of 100%, negative predictive value of
66.7%, and accuracy of 97%. Triple diagnostic test may be used as
an option of diagnostic method in hospitals where frozen section
examination is not available.
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